Analystreport

Aktis Oncology (AKTS) is now covered by William Blair. They set an "outperform" rating on the stock.

Aktis Oncology, Inc. - Common stock  (AKTS) 
NASDAQ:AMEX Investor Relations: ir.akoustis.com